Skip to main content
. 2022 Nov 8;3(4):101829. doi: 10.1016/j.xpro.2022.101829
Target type Target name Sequence Foundations used in replicates
Spot-Tag∗ (peptide target) Spot-Tag.01 (N-terminus)-PDRVRAVSHWSSGGG-Cys
(C-terminus)-3′ATCCCTTCTCTTCCTGTAT
ACTAATAGGTGCACGTAGATTC/5Phos/
Fd31, Fd19, Fd20, Fd27, Fd28, Fd29
Bradykinin∗
(peptide target
control for
non-specific
binding)
Brady.01 (N-terminus)-RPPGFSPFR-Cys
(C-terminus)-3′ATCCCTTCTCTTCCTGTAT
ACTAATAGGTGCACGTAGATTC/5Phos/
Fd12, Fd13, Fd14
DNA∗∗
(null control)
CLR.Null.Block CTTAGATGCACGTGGATAAT Fd24, Fd25, Fd26
DNA∗∗
(null control)
5′Phos.01 /5Phos/CTTAGATGCACGTGGATA Fd7, Fd8, Fd11
DNA∗∗ (positive
control)
DNA Target 6.01 /5Phos/CTTAGATGCACGTGGATAATCATA
TGTCCTTCTCTTCCCTAATGAAGTAC
TAA CCTGA
Fd21, Fd22, Fd23
DNA∗∗ (positive
control)
DNA Target 4.01 /5Phos/CTTAGATGCACGTGGATAATCATA TGTCCTTCTCTTCCCTAATAGGATTCC Fd15, Fd16, Fd17

∗The C-terminal of the peptide targets is directly conjugated to the 3′ end of one DNA tail via a cysteine.

∗∗Binding sequences and DNA tails of DNA targets are continuous oligos rather than conjugated through another chemical conjugation method.